col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


36 Results       Page 1

 [1] 
Springer-Verlag: Inflammopharmacology
  original article Date Title Authors   All Authors
1 [GO] 2022―May―13 COVID-19 and corticosteroids: a narrative review Gaber El-Saber Batiha, Ali I. Al-Gareeb, Hebatallah M. Saad, Hayder M. Al-kuraishy
2 [GO] 2022―May―04 COVID-19 and the role of cytokines in this disease Amin Hasanvand
3 [GO] 2022―Apr―29 A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19 Gomaa Mostafa-Hedeab, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Philippe Jeandet, Hebatallah M. Saad, Gaber El-Saber Batiha
4 [GO] 2022―Apr―26 High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Ola A. Habotta, Gaber El-Saber Batiha
5 [GO] 2022―Apr―07 Potential plants for inflammatory dysfunction in the SARS-CoV-2 infection Diorge Jônatas Marmitt
6 [GO] 2022―Mar―28 Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies Yrna Lorena Matos de Oliveira, Ayane de Sá Resende, Paulo Ricardo Martins-Filho, Tatiana Rodrigues de Moura
7 [GO] 2022―Mar―23 Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR Nourin Shakeeb, Prashanth Varkey, Aimy Hynse, Ajit Mandlecha
8 [GO] 2022―Mar―22 Comment on “Inflawell, neutrophil-to-lymphocyte ratio and COVID-19 Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
9 [GO] 2022―Mar―01 Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial Adel A. Gomaa, Hamdy S. Mohamed, Rasha B. Abd-ellatief, Mohamed A. Gomaa, Doaa S. Hammam
10 [GO] 2022―Feb―24 Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial Sepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, Mohammadreza Salehi, Abbas Tafakhori, Mohammad Reza Shahmohammadi, et al. (+13)
11 [GO] 2022―Feb―14 Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery A. Skesters, D. Kustovs, A. Lece, E. Moreino, E. Petrosina, K. D. Rainsford
12 [GO] 2022―Jan―31 Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19 Parisa Feizollahi, Somaieh matin, Seyed Askar Roghani, Shayan Mostafaei, Elham Safarzadeh, Mahdi Taghadosi
13 [GO] 2022―Jan―31 The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis Chia Siang Chia Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
14 [GO] 2022―Jan―20 Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Suresh Sharma, Yogendra S. Padwad, Sanjay Kumar
15 [GO] 2022―Jan―03 Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, Pragati Sood, Jiki Robert
16 [GO] 2021―Dec―20 Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery
17 [GO] 2021―Nov―25 NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Mina T. Kelleni
18 [GO] 2021―Oct―28 The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery
19 [GO] 2021―Aug―09 Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Nahid Abbas, Prasad Sanjay Dhiwar, Abhishek Ghara, Arka Das
20 [GO] 2021―Jul―31 Recent updates on immunological, pharmacological, and alternative approaches to combat COVID-19 Ammara Saleem, Muhammad Furqan Akhtar, Muhammad Haris, Mohamed M. Abdel-Daim
21 [GO] 2021―Jul―19 COVID-19 vaccines and decreased transmission of SARS-CoV-2 A. Vitiello, F. Ferrara, V. Troiano, R. La Porta
22 [GO] 2021―Jul―09 SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism Ali Sepehrinezhad, Ali Gorji, Sajad Sahab Negah
23 [GO] 2021―Jul―05 Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly Adel A. Gomaa, Hamdy S. Mohamed, Rasha Bakheet Abd-ellatief, Mohamed A. Gomaa
24 [GO] 2021―Jun―29 Shedding light on vitamin D: the shared mechanistic and pathophysiological role between hypovitaminosis D and COVID-19 risk factors and complications Esraa Menshawey, Rahma Menshawey, Omnia Azmy Nabeh
25 [GO] 2021―Jun―10 Role of vitamins and minerals as immunity boosters in COVID-19 Puneet Kumar, Mandeep Kumar, Onkar Bedi, Manisha Gupta, Sachin Kumar, Gagandeep Jaiswal, et al. (+5)
26 [GO] 2021―May―03 Brief review of the mRNA vaccines COVID-19 Antonio Vitiello, Francesco Ferrara
27 [GO] 2021―Apr―21 The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis Chia Siang Kow, Syed Shahzad Hasan
28 [GO] 2021―Apr―06 Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection Menizibeya O. Welcome, Nikos E. Mastorakis
29 [GO] 2021―Mar―15 Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting Sreedhar Amere Subbarao
30 [GO] 2021―Feb―20 Correction to: COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen, Raghdaa Al Zarzour
31 [GO] 2020―Nov―16 COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials Desley Butters, Michael Whitehouse
32 [GO] 2020―Nov―07 The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, Mettu Srinivas Reddy, Mohamed Rela
33 [GO] 2020―Sep―12 ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror Mina T. Kelleni
34 [GO] 2020―Aug―14 A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality Lucinda Smart, Neil Fawkes, Paul Goggin, Graham Pennick, K. D. Rainsford, Bruce Charlesworth, Neil Shah
35 [GO] 2020―Aug―14 COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen, Raghdaa Al Zarzour
36 [GO] 2020―Jul―07 A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms Kevin Roe
 [1] 

36 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.017 sec